Skip to main content
. 2014 Sep 23;24(3):865–874. doi: 10.1093/hmg/ddu478

Table 1.

Study sample characteristics

Study n Male/female (% male) Age, years (S.D.) SBP, mmHg (S.D.) DBP, mmHg (S.D.) BMI, kg/m2 (S.D.) HTN (%)a Antihypertensive therapy (%)
Discovery meta-analysis (n = 11 816)
 InterASIA-1 3998 1870/2128 (46.8) 52.5 (7.7) 140.7 (24.7) 88.1 (14.8) 25.2 (3.8) 61.3 26.7
 Beijing 466 363/103 (77.9) 51.1 (9.5) 120.6 (12.8) 77.9 (8.4) 24.6 (3.4) 4.5 0
 GenSalt 1881 993/888 (52.8) 38.7 (9.5) 116.9 (14.2) 73.7 (10.3) 23.4 (3.2) 9.8 0.4
 NHAPC 2893 1251/1642 (43.2) 58.6 (6.0) 140.2 (22.7) 80.2 (10.9) 24.5 (3.6) 55.0 28.3
 Nanjing 1146 820/326 (71.6) 59.0 (9.7) 129.6 (21.1) 81.0 (10.7) 23.1 (3.2) 39.5 18.7
 DFTJ 1432 1118/314 (78.1) 63.1 (8.1) 130.0 (18.9) 78.3 (11.0) 24.7 (3.3) 39.8 30.8
Replication 1
 InterASIA-2 12 108 5872/6236 (48.5) 52.6 (8.3) 136.4 (24.8) 84.0 (13.5) 25.0 (3.7) 48.7 20.5
Replication 2
 CCHS-1 22 896 12794/10102 (55.9) 52.7 (9.5) 130.3 (21.6) 80.9 (11.7) 23.8 (3.5) 35.5 14.0
Replication 3
 CCHS-2 34 142 13199/20943 (38.7) 52.2 (12.1) 133.2 (20.1) 81.4 (11.2) 24.3 (3.7) 46.2 15.3

InterASIA, International Collaborative Study of Cardiovascular Disease in Asia (InterASIA in China); Beijing, Beijing Cardiovascular Risk Factors study; GenSalt, the Genetic Epidemiology Network of Salt-Sensitivity study; NHAPC, The Nutrition and Health of Aging Population in China; Nanjing, Noncommunicable Diseases Screening study in Nanjing; DFTJ, The Dongfeng-Tongji cohort study; CCHS-1, China Cardiovascular Health Study project (Jiangsu); CCHS-2, China Cardiovascular Health Study project (Shandong and Henan); n, sample size; S.D., standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; BMI, body mass index.

a

Hypertension is defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg or taking antihypertensive medication.